drug · small molecule
patient view →etavopivat
Phase 3updated 2mo agoby Novo Nordisk AS🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 4 investigational indications.
indications
indications
Sickle Cell Disease
targets
Pyruvate kinase PKLR
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that